LABCORP HOLDINGS INC (LH) Fundamental Analysis & Valuation
NYSE:LH • US5049221055
Current stock price
260.065 USD
+2.93 (+1.14%)
Last:
This LH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LH Profitability Analysis
1.1 Basic Checks
- In the past year LH was profitable.
- In the past year LH had a positive cash flow from operations.
- LH had positive earnings in each of the past 5 years.
- LH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 4.77%, LH is doing good in the industry, outperforming 76.00% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 10.17%, LH is in the better half of the industry, outperforming 69.00% of the companies in the same industry.
- LH has a better Return On Invested Capital (7.65%) than 74.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for LH is in line with the industry average of 8.40%.
- The 3 year average ROIC (6.71%) for LH is below the current ROIC(7.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.77% | ||
| ROE | 10.17% | ||
| ROIC | 7.65% |
ROA(3y)3.77%
ROA(5y)5.87%
ROE(3y)8.25%
ROE(5y)12.11%
ROIC(3y)6.71%
ROIC(5y)8.38%
1.3 Margins
- LH has a better Profit Margin (6.28%) than 83.00% of its industry peers.
- In the last couple of years the Profit Margin of LH has declined.
- LH's Operating Margin of 10.87% is amongst the best of the industry. LH outperforms 81.00% of its industry peers.
- LH's Operating Margin has declined in the last couple of years.
- LH has a Gross Margin (28.76%) which is comparable to the rest of the industry.
- LH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.87% | ||
| PM (TTM) | 6.28% | ||
| GM | 28.76% |
OM growth 3Y-9.72%
OM growth 5Y-12.74%
PM growth 3Y-16.48%
PM growth 5Y-10.81%
GM growth 3Y-2.74%
GM growth 5Y-4.09%
2. LH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
- The number of shares outstanding for LH has been reduced compared to 1 year ago.
- LH has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for LH has been reduced compared to a year ago.
2.2 Solvency
- LH has an Altman-Z score of 3.06. This indicates that LH is financially healthy and has little risk of bankruptcy at the moment.
- LH's Altman-Z score of 3.06 is fine compared to the rest of the industry. LH outperforms 69.00% of its industry peers.
- LH has a debt to FCF ratio of 4.69. This is a neutral value as LH would need 4.69 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 4.69, LH is doing good in the industry, outperforming 61.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.60 indicates that LH is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.60, LH perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 3.06 |
ROIC/WACC0.91
WACC8.4%
2.3 Liquidity
- LH has a Current Ratio of 1.42. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
- LH has a Current ratio (1.42) which is in line with its industry peers.
- A Quick Ratio of 1.23 indicates that LH should not have too much problems paying its short term obligations.
- The Quick ratio of LH (1.23) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.23 |
3. LH Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 12.83% over the past year.
- LH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.22% yearly.
- LH shows a small growth in Revenue. In the last year, the Revenue has grown by 7.25%.
- The Revenue has been decreasing by -0.04% on average over the past years.
EPS 1Y (TTM)12.83%
EPS 3Y-6.14%
EPS 5Y-7.22%
EPS Q2Q%17.97%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y5.55%
Revenue growth 5Y-0.04%
Sales Q2Q%5.6%
3.2 Future
- Based on estimates for the next years, LH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.36% on average per year.
- The Revenue is expected to grow by 4.70% on average over the next years.
EPS Next Y11.45%
EPS Next 2Y9.95%
EPS Next 3Y9.51%
EPS Next 5Y8.36%
Revenue Next Year4.85%
Revenue Next 2Y4.8%
Revenue Next 3Y4.8%
Revenue Next 5Y4.7%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. LH Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 15.82, the valuation of LH can be described as correct.
- Based on the Price/Earnings ratio, LH is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of LH to the average of the S&P500 Index (26.54), we can say LH is valued slightly cheaper.
- A Price/Forward Earnings ratio of 14.19 indicates a correct valuation of LH.
- Based on the Price/Forward Earnings ratio, LH is valued a bit cheaper than the industry average as 76.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, LH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 14.19 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, LH is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, LH is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.72 | ||
| EV/EBITDA | 11.95 |
4.3 Compensation for Growth
- LH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- LH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.38
PEG (5Y)N/A
EPS Next 2Y9.95%
EPS Next 3Y9.51%
5. LH Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.09%, LH has a reasonable but not impressive dividend return.
- LH's Dividend Yield is rather good when compared to the industry average which is at 0.45. LH pays more dividend than 87.00% of the companies in the same industry.
- With a Dividend Yield of 1.09, LH pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.09% |
5.2 History
- LH has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 27.46% of the earnings are spent on dividend by LH. This is a low number and sustainable payout ratio.
DP27.46%
EPS Next 2Y9.95%
EPS Next 3Y9.51%
LH Fundamentals: All Metrics, Ratios and Statistics
NYSE:LH (4/30/2026, 1:01:40 PM)
260.065
+2.93 (+1.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth88.82
Earnings (Last)04-30 2026-04-30/bmo
Earnings (Next)N/A N/A
Inst Owners100.01%
Inst Owner Change0.01%
Ins Owners0.39%
Ins Owner Change7.13%
Market Cap21.37B
Revenue(TTM)13.95B
Net Income(TTM)876.50M
Analysts82.76
Price Target313.59 (20.58%)
Short Float %3.96%
Short Ratio5.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.09% |
Yearly Dividend2.91
Dividend Growth(5Y)N/A
DP27.46%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2026-05-29 (0.72)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.79%
Min EPS beat(2)-1.84%
Max EPS beat(2)0.26%
EPS beat(4)2
Avg EPS beat(4)-0.15%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)4
Avg EPS beat(8)-0.03%
EPS beat(12)5
Avg EPS beat(12)-0.44%
EPS beat(16)6
Avg EPS beat(16)-0.53%
Revenue beat(2)0
Avg Revenue beat(2)-3.43%
Min Revenue beat(2)-4.07%
Max Revenue beat(2)-2.8%
Revenue beat(4)0
Avg Revenue beat(4)-3.25%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.56%
Revenue beat(12)0
Avg Revenue beat(12)-4.2%
Revenue beat(16)0
Avg Revenue beat(16)-9.31%
PT rev (1m)1.18%
PT rev (3m)2.57%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.3%
EPS NY rev (3m)1.66%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 14.19 | ||
| P/S | 1.53 | ||
| P/FCF | 17.72 | ||
| P/OCF | 13.03 | ||
| P/B | 2.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.95 |
EPS(TTM)16.44
EY6.32%
EPS(NY)18.32
Fwd EY7.05%
FCF(TTM)14.67
FCFY5.64%
OCF(TTM)19.96
OCFY7.67%
SpS169.75
BVpS104.88
TBVpS-21.48
PEG (NY)1.38
PEG (5Y)N/A
Graham Number196.961 (-24.26%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.77% | ||
| ROE | 10.17% | ||
| ROCE | 9.74% | ||
| ROIC | 7.65% | ||
| ROICexc | 7.92% | ||
| ROICexgc | 25.61% | ||
| OM | 10.87% | ||
| PM (TTM) | 6.28% | ||
| GM | 28.76% | ||
| FCFM | 8.64% |
ROA(3y)3.77%
ROA(5y)5.87%
ROE(3y)8.25%
ROE(5y)12.11%
ROIC(3y)6.71%
ROIC(5y)8.38%
ROICexc(3y)7.11%
ROICexc(5y)8.91%
ROICexgc(3y)25.11%
ROICexgc(5y)31.96%
ROCE(3y)8.54%
ROCE(5y)10.67%
ROICexgc growth 3Y-5.21%
ROICexgc growth 5Y-15.54%
ROICexc growth 3Y-1.42%
ROICexc growth 5Y-12.05%
OM growth 3Y-9.72%
OM growth 5Y-12.74%
PM growth 3Y-16.48%
PM growth 5Y-10.81%
GM growth 3Y-2.74%
GM growth 5Y-4.09%
F-Score8
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.34 | ||
| Cap/Depr | 63.79% | ||
| Cap/Sales | 3.11% | ||
| Interest Coverage | 6.96 | ||
| Cash Conversion | 74.66% | ||
| Profit Quality | 137.59% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 3.06 |
F-Score8
WACC8.4%
ROIC/WACC0.91
Cap/Depr(3y)72.83%
Cap/Depr(5y)71.26%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.64%
Profit Quality(3y)164.54%
Profit Quality(5y)144.06%
High Growth Momentum
Growth
EPS 1Y (TTM)12.83%
EPS 3Y-6.14%
EPS 5Y-7.22%
EPS Q2Q%17.97%
EPS Next Y11.45%
EPS Next 2Y9.95%
EPS Next 3Y9.51%
EPS Next 5Y8.36%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y5.55%
Revenue growth 5Y-0.04%
Sales Q2Q%5.6%
Revenue Next Year4.85%
Revenue Next 2Y4.8%
Revenue Next 3Y4.8%
Revenue Next 5Y4.7%
EBIT growth 1Y33.23%
EBIT growth 3Y-4.71%
EBIT growth 5Y-12.77%
EBIT Next Year28.32%
EBIT Next 3Y12.23%
EBIT Next 5YN/A
FCF growth 1Y10.05%
FCF growth 3Y-6.47%
FCF growth 5Y-7.21%
OCF growth 1Y3.45%
OCF growth 3Y-5.69%
OCF growth 5Y-5.14%
LABCORP HOLDINGS INC / LH Fundamental Analysis FAQ
What is the ChartMill fundamental rating of LABCORP HOLDINGS INC (LH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to LH.
Can you provide the valuation status for LABCORP HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.
How profitable is LABCORP HOLDINGS INC (LH) stock?
LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for LH stock?
The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 15.82 and the Price/Book (PB) ratio is 2.48.
How financially healthy is LABCORP HOLDINGS INC?
The financial health rating of LABCORP HOLDINGS INC (LH) is 6 / 10.